Other functions preclinical efficacy and intermediate endpoint biomarkers - task order d - characterization of potential antigens for immunization against colon cancer, and testing multivalent tumor…
Ended Awarded Last action
- Contract number
- HHSN26100003
- Awardee
-
University Of Oklahoma UEI GY8NMUZQXVS7
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $649,174
Award facts
- Opportunity
-
- N01CN2500278 Solicitation number
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Feb 27, 2012
- Preclinical Efficacy and Intermediate Endpoint Biomarkers Award Notice · Posted Dec 15, 2011
- Contract value 100% obligated
- $649,174.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541711 Research and Development in Biotechnology
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 2 offers Multiple Award, Fair Opportunity
- Pricing
- Cost No Fee
- Place of performance
- Oklahoma City, OK 73104, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | -$1,513 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Modification | $650,687 | |
| Other Administrative Action | $0 |
Description
Other functions preclinical efficacy and intermediate endpoint biomarkers - task order d - characterization of potential antigens for immunization against colon cancer, and testing multivalent tumor vaccines in min mice
Quick answers
Who was awarded contract HHSN26100003?
HHSN26100003 was awarded to University Of Oklahoma by National Cancer Institute (National Institutes of Health) on September 21, 2012.
How much is contract HHSN26100003 worth?
The government has obligated $649,174 on HHSN26100003.
Is contract HHSN26100003 an order under another contract?
Yes. HHSN26100003 is a delivery order under HHSN261201200013I, an indefinite delivery contract, on Preclinical Efficacy and Intermediate Endpoint Biomarkers.
Was contract HHSN26100003 competed?
The extent of competition for HHSN26100003 was full and open competition. The government received 2 offers.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award